Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Herpes Labialis (Oral Herpes) – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. The…
DUBLIN–(BUSINESS WIRE)–The “Herpes Labialis (Oral Herpes) – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. The…
DUBLIN–(BUSINESS WIRE)–The “Herpes Labialis (Oral Herpes) – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. The…
LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE:ADCT), a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent…
LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE:ADCT), a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent…
LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE:ADCT), a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent…
LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE:ADCT), a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent…
LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE:ADCT), a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent…
– Vutrisiran Met Primary and All Secondary Endpoints at 9 Months, with Statistically Significant Improvements in Progression of Neuropathy, Quality…
— First and only prescription therapy approved specifically for short-term treatment of the signs and symptoms of dry eye disease…